Latest News

2-Year MIMICS Data Confirm Long-term Patency Protection With BioMimics 3D.

6 February 2014 – Seroba Kernel's investee company, Veryan Medical Ltd, presented two-year follow-up data at the annual Leipzig Interventional Course (LINC) today. The two-year data has shown that a nitinol stent with unique three-dimensional helical geometry, BioMimics 3D™, developed by Veryan Medical Ltd, (Horsham, UK) provides an improvement in long-term patency compared...


Quanta Fluid Solutions Ltd Appoints New Chief Executive Officer.

Alcester, Warwickshire, UK, 8 January 2014: Seroba Kernel investee company, Quanta Fluid Solutions Ltd, a pioneering medical devices company that is developing advanced haemodialysis systems for patient self-care and dialysis centres, today announces the appointment of John E. Milad as Chief Executive Officer. John’s career spans twenty years, with extensive experience...


Ario Pharma Ltd Founded to Develop Novel Therapeutics for Respiratory Indications.

Cambridge, UK, 11th December 2013: Ario Pharma Ltd, a new biopharmaceutical company, has been founded to develop innovative new approaches to treat respiratory disease. Based in Cambridge, UK, Ario Pharma is a spin out from Xention Pharma Ltd, a specialist ion channel R&D company. Ario Pharma announced today that it has successfully raised £1.9 million ($3.1 million) from...


< back to home page